Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03856463 · ClinicalTrials.gov registry record · NA

Coaches Activating Reaching and Engaging Patients

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
400
Enrollment target

NCT03856463: Completed NA study, sponsored by Stanford University.

NCT03856463 is a NA study that has completed, run by Stanford University. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03856463, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target

Study Summary

The purpose of the Team Based Advance Care Planning CAREPLAN program is to understand if a trained lay navigator who engages with patients with advanced stages of cancer can help patients in advance care planning, improve patient activation, satisfaction, quality of life, and the quality of end of life cancer care while also ensuring goal concordant cancer care at the end of life.

Primary Outcome

Goals of Care documentation for each patient will be abstracted by electronic medical record chart review for each patient at 12 months after enrollment.

Interventions

  • OTHER Usual Care
  • BEHAVIORAL Lay Navigator Intervention

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2019-04-03
Est. Completion 2023-09-25
Phase NA
Stanford University

1,744 total trials

What the finished NCT03856463 record still lists

NCT03856463 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).

The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.

NCT03856463 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03856463 about?

NCT03856463 is a clinical study titled "Coaches Activating Reaching and Engaging Patients". The purpose of the Team Based Advance Care Planning CAREPLAN program is to understand if a trained lay navigator who engages with patients with advanced stages of cancer can help patients in advance care planning, improve patient activation, satisfaction, quality of life, and the quality of end of l...

What is the current status of trial NCT03856463?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2019-04-03. Estimated completion is 2023-09-25.

What interventions are being tested in trial NCT03856463?

The interventions under investigation include: Usual Care (OTHER), Lay Navigator Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03856463?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03856463's enrollment target sits among peer trials

400 246th of 2000 higher than 1,734 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03856463, the US trial registry maintained by the National Library of Medicine. NCT03856463 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.